NEUROFIBROMATOSIS THERAPEUTIC ACCELERATION PROGRAM (NTAP)
No limit for direct and total costs but the direct costs should be appropriate and well justified (indirect costs: 10%) - There is no Deadline for Submission.
Johns Hopkins University School of MedicineThe Program supports research projects designed to accelerate development of effective treatments for NF1 associated peripheral nerve sheath tumors through the Open Proposal Program.
